Skip to main content
Wolfson Institute of Population Health - Barts and The London

In the Press

Trial of HPV vaccine completed: more effective cancer prevention
8 August 2017

A new HPV (human papilloma virus) vaccine that protects against 9 types of the virus – 7 of which cause most cases of cervical cancer – has now been fully tested in a trial co-organised by Professor Jack Cuzick.

The new vaccine offers significantly greater protection than the current vaccine, which protects against only two cancer-causing types of HPV.